Submit a comment
Ushma S. Neill, … , Marc Feldmann, William N. Kelley
Citation Information: J Clin Invest. 2007;117(3):506-508. https://doi.org/10.1172/JCI31587.
Ushma S. Neill, … , Marc Feldmann, William N. Kelley
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):506-508. https://doi.org/10.1172/JCI31587.
Abstract
As stewards of the JCI, we are responsible for instituting and sustaining the highest possible standards for integrity. To this end, we have established a very specific set of guidelines for handling potential conflicts of interest — not only for authors and referees, but also for ourselves.
Authors
Ushma S. Neill, Craig B. Thompson, Marc Feldmann, William N. Kelley
Guidelines
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.
- Comments appear on the Journal’s website and are linked from the original article’s web page.
- Authors are notified by email if their comments are posted.
- The Journal reserves the right to edit comments for length and clarity.
- No appeals will be considered.
- Comments are not indexed in PubMed.
Specific requirements
- Maximum length, 400 words
- Entered as plain text or HTML
- Author’s name and email address, to be posted with the comment
- Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
- Comments may not include figures
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)